Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9979191 | The Journal of Thoracic and Cardiovascular Surgery | 2005 | 8 Pages |
Abstract
An improved survival associated with transient reorganization of the cytoskeletal proteins and reduction in myocardial fibrosis was achieved by hepatocyte growth factor treatment in an adult hamster model of dilated cardiomyopathy. The results suggest a therapeutic potential of hepatocyte growth factor in the treatment of dilated cardiomyopathy.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Haruhiko MD, Yoshiki MD, Norihide MD, Goro MD, Shigeru MD, Satoru MD, Imran A. MD, Naomasa MD, Nariaki MD, Hikaru MD,